2023 ACR/EULAR antiphospholipid syndrome classification criteria

被引：142

作者：

Barbhaiya, Medha ^{[1
]}

Zuily, Stephane ^{[2
,3
]}

Naden, Ray ^{[4
]}

Hendry, Alison ^{[5
]}

Manneville, Florian ^{[6
]}

Amigo, Mary-Carmen ^{[7
]}

Amoura, Zahir ^{[8
]}

Andrade, Danieli ^{[9
]}

Andreoli, Laura ^{[10
]}

Artim-Esen, Bahar ^{[11
]}

Atsumi, Tatsuya ^{[12
]}

Avcin, Tadej ^{[13
]}

Belmont, Michael H. ^{[14
]}

Bertolaccini, Maria Laura ^{[15
]}

Branch, D. Ware ^{[16
]}

Carvalheiras, Graziela ^{[17
]}

Casini, Alessandro ^{[18
]}

Cervera, Ricard ^{[19
]}

Cohen, Hannah ^{[20
]}

Costedoat-Chalumeau, Nathalie ^{[21
]}

Crowther, Mark ^{[22
]}

de Jesus, Guilherme ^{[23
]}

Delluc, Aurelien ^{[24
,25
]}

Desai, Sheetal ^{[26
]}

De Sancho, Maria ^{[27
]}

Devreese, Katrien M. ^{[28
,29
]}

Diz-Kucukkaya, Reyhan ^{[30
]}

Duarte-Garcia, Ali ^{[31
]}

Frances, Camille ^{[32
]}

Garcia, David ^{[33
]}

Gris, Jean-Christophe ^{[34
]}

Jordan, Natasha ^{[35
]}

Leaf, Rebecca K. ^{[36
]}

Kello, Nina ^{[37
]}

Knight, Jason S. ^{[38
]}

Laskin, Carl ^{[39
]}

Lee, Alfred I. ^{[40
]}

Legault, Kimberly ^{[41
]}

Levine, Steve R. ^{[42
,43
]}

Levy, Roger A. ^{[44
,45
]}

Limper, Maarten ^{[46
]}

Lockshin, Michael D. ^{[1
]}

Mayer-Pickel, Karoline ^{[47
]}

Musial, Jack ^{[48
]}

Meroni, Pier Luigi ^{[49
]}

Orsolini, Giovanni ^{[50
]}

Ortel, Thomas L. ^{[51
]}

Pengo, Vittorio ^{[52
]}

Petri, Michelle ^{[53
]}

Pons-Estel, Guillermo ^{[54
]}

机构：

[1] Weill Cornell Med, Hosp Special Surg, Barbara Volcker Ctr Women & Rheumat Dis, New York, NY USA

[2] Univ Lorraine, French Natl Referral Ctr System & Autoimmune Dis, Vasc Med Div, Inserm,DCAC, Nancy, France

[3] CHRU Nancy, Nancy, France

[4] Auckland City Hosp, Dept Med & Obstet, Auckland, New Zealand

[5] Middlemore Hosp, Dept Gen Med, Auckland, New Zealand

[6] Univ Lorraine, Inserm, CHRU Nancy, CIC Clin Epidemiol, Nancy, France

[7] ABC Med Ctr, Dept Internal Med, Serv Rheumatol, Mexico City, Mexico

[8] Sorbonne Univ, Ctr Immunol & Malad Infect,Hop Pitie Salpetriere, French Natl Reference Ctr System Lupus Erythemat, Antiphospholipid Antibody Syndrome,Serv Med Inter, Paris, France

[9] Univ Sao Paulo, Dept Rheumatol, Sao Paulo, Brazil

[10] Univ Brescia, Rheumatol & Clin Immunol Unit, ASST Spedali Civili, Dept Clin & Expt Sci, Brescia, Italy

[11] Istanbul Univ, Sch Med, Dept Rheumatol, Istanbul, Turkiye

[12] Hokkaido Univ, Dept Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan

[13] Univ Ljubljana, Univ Med Ctr, Childrens Hosp, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia

[14] NYU, Hosp Joint Dis, Dept Rheumatol, New York, NY USA

[15] Kings Coll London, Sch Cardiovasc & Metab Med & Sci, Acad Dept Vasc Surg, London, England

[16] Univ Utah Hlth, Dept Obstet & Gynecol, Salt Lake City, UT USA

[17] Ctr Hosp Porto, Hosp Santo Antonio, Unidade Imunol Clin, Porto, Portugal

[18] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland

[19] Univ Barcelona, Hosp Clin, Dept Autoimmune Dis, Barcelona, Spain

[20] UCL, Dept Haematol, London, England

[21] Univ Paris, Hop Cochin, AP HP, Serv Med Interne,Ctr Reference Malad Autoimmune &, Paris, France

[22] McMaster Univ, Dept Med, Hamilton, ON, Canada

[23] Univ Estado Rio de Janeiro, Dept Obstet, Rio De Janeiro, Brazil

[24] Univ Ottawa, Dept Med, Ottawa, ON, Canada

[25] Ottawa Hosp, Res Inst, Ottawa, ON, Canada

[26] Univ Calif Irvine, Div Rheumatol, Irvine, CA USA

[27] Weill Cornell Med, Div Hematol & Oncol, New York, NY USA

[28] Ghent Univ Hosp, Dept Lab Med, Coagulat Lab, Ghent, Belgium

[29] Univ Ghent, Dept Diagnost Sci, Ghent, Belgium

[30] Istanbul Univ, Dept Mol Biol & Genet, Sch Sci, Istanbul, Turkiye

[31] Mayo Clin, Div Rheumatol, Rochester, MN USA

[32] Tenon Hosp, Dept Dermatol Allergol, Paris, France

[33] Univ Washington, Dept Hematol, Seattle, WA USA

[34] Univ Montpellier, UMR UA11, INSERM, Dept Hematol,CHRU Nimes, Montpellier, France

[35] Addenbrookes Hosp, Dept Rheumatol, Cambridge, England

[36] Massachusetts Gen Hosp, Dept Hematol, Boston, MA USA

[37] Northwell Hlth, Div Rheumatol, New York, NY USA

[38] Univ Michigan, Div Rheumatol, Ann Arbor, MI USA

[39] Univ Toronto, TRIO Fertil, Div Rheumatol, Toronto, ON, Canada

[40] Yale Sch Med, Dept Hematol, New Haven, CT USA

[41] McMaster Univ, Div Rheumatol, Hamilton, ON, Canada

[42] Suny Downstate Hlth Sci Univ, Downstate Stroke Ctr, Kings Cty Hosp Ctr, Brooklyn, NY USA

[43] Jaffe Stroke Ctr, Maimonides Med Ctr, Brooklyn, NY USA

[44] Univ Estado Rio de Janeiro, Dept Rheumatol, Rio De Janeiro, Brazil

[45] GlaxoSmithKline, Collegeville, PA USA

[46] Univ Utrecht, Univ Med Ctr, Dept Med & Clin Immunol, Utrecht, Netherlands

[47] Med Univ Graz, Dept Obstet, Graz, Austria

[48] Jagiellonian Univ, Sch Med, Dept Med, Krakow, Poland

[49] IRCCS Ist Auxol Italiano, Immunorheumatol Res Lab, Milan, Italy

[50] Univ Hosp Verona, Dept Rheumatol, Verona, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷 / 10期

关键词：

antiphospholipid syndrome; thrombosis; antibodies; antiphospholipid; INTERNATIONAL CONSENSUS STATEMENT; SYSTEMIC-SCLEROSIS; ISCHEMIC-STROKE; ANTIBODIES; DIAGNOSIS; UPDATE;

D O I：

10.1136/ard-2023-224609

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective To develop new antiphospholipid syndrome (APS) classification criteria with high specificity for use in observational studies and trials, jointly supported by the American College of Rheumatology (ACR) and EULAR. Methods This international multidisciplinary initiative included four phases: (1) Phase I, criteria generation by surveys and literature review; (2) Phase II, criteria reduction by modified Delphi and nominal group technique exercises; (3) Phase III, criteria definition, further reduction with the guidance of real-world patient scenarios, and weighting via consensus-based multicriteria decision analysis, and threshold identification; and (4) Phase IV, validation using independent adjudicators' consensus as the gold standard. Results The 2023 ACR/EULAR APS classification criteria include an entry criterion of at least one positive antiphospholipid antibody (aPL) test within 3 years of identification of an aPL-associated clinical criterion, followed by additive weighted criteria (score range 1-7 points each) clustered into six clinical domains (macrovascular venous thromboembolism, macrovascular arterial thrombosis, microvascular, obstetric, cardiac valve, and hematologic) and two laboratory domains (lupus anticoagulant functional coagulation assays, and solid-phase enzyme-linked immunosorbent assays for IgG/IgM anticardiolipin and/or IgG/IgM anti-beta(2)-glycoprotein I antibodies). Patients accumulating at least three points each from the clinical and laboratory domains are classified as having APS. In the validation cohort, the new APS criteria vs the 2006 revised Sapporo classification criteria had a specificity of 99% vs 86%, and a sensitivity of 84% vs 99%. Conclusion These new ACR/EULAR APS classification criteria were developed using rigorous methodology with multidisciplinary international input. Hierarchically clustered, weighted, and risk-stratified criteria reflect the current thinking about APS, providing high specificity and a strong foundation for future APS research.

引用

页码：1258 / 1270

页数：13

共 44 条

[1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
ADAMS, HP
BENDIXEN, BH
KAPPELLE, LJ
BILLER, J
LOVE, BB
GORDON, DL
MARSH, EE
KASE, CS
WOLF, PA
BABIKIAN, VL
LICATAGEHR, EE
ALLEN, N
BRASS, LM
FAYAD, PB
PAVALKIS, FJ
WEINBERGER, JM
TUHRIM, S
RUDOLPH, SH
HOROWITZ, DR
BITTON, A
MOHR, JP
SACCO, RL
CLAVIJO, M
ROSENBAUM, DM
SPARR, SA
KATZ, P
KLONOWSKI, E
CULEBRAS, A
CAREY, G
MARTIR, NI
FICARRA, C
HOGAN, EL
CARTER, T
GURECKI, P
MUNTZ, BK
RAMIREZLASSEPAS, M
TULLOCH, JW
QUINONES, MR
MENDEZ, M
ZHANG, SM
ALA, T
JOHNSTON, KC
ANDERSON, DC
TARREL, RM
NANCE, MA
BUDLIE, SR
DIERICH, M
HELGASON, CM
HIER, DB
SHAPIRO, RA
[J]. STROKE, 1993, 24 (01) : 35 - 41
[2] Distinctions Between Diagnostic and Classification Criteria?
Aggarwal, Rohit
Ringold, Sarah
Khanna, Dinesh
Neogi, Tuhina
Johnson, Sindhu R.
Miller, Amy
Brunner, Hermine I.
Ogawa, Rikke
Felson, David
Ogdie, Alexis
Aletaha, Daniel
Feldman, Brian M.
[J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (07) : 891 - 897
[3] The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping)
Amarenco, P.
Bogousslavsky, J.
Caplan, R.
Donnan, G. A.
Wolf, M. E.
Hennerici, M. G.
[J]. CEREBROVASCULAR DISEASES, 2013, 36 (01) : 1 - 5
[4] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (vol 41, pg 255, 2019)
Ghodbhane, W.
[J]. EUROPEAN HEART JOURNAL, 2020, 41 (45) : 4317 - 4317
[5] [Anonymous], 2020, Obstet Gynecol, V135, P1492, DOI [10.1097/AOG.0000000000003018, 10.1097/AOG.0000000000003892]
[6] Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1002/art.40930, 10.1136/annrheumdis-2018-214819]
[7] DEVELOPMENT OF NEW INTERNATIONAL CLASSIFICATION CRITERIA FOR ANTIPHOSPHOLIPID SYNDROME: PHASE III CASE COLLECTION RESULTS
Barbhaiya, M.
Erkan, D.
Ahmadzadeh, Y.
Costenbader, K.
Naden, R.
Zuily, S.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 64 - 64
[8] Barbhaiya M., 2016, LUPUS, V25
[9] 2023 ACR/EULAR antiphospholipid syndrome classification criteria
Barbhaiya, Medha
Zuily, Stephane
Naden, Ray
Hendry, Alison
Manneville, Florian
Amigo, Mary-Carmen
Amoura, Zahir
Andrade, Danieli
Andreoli, Laura
Artim-Esen, Bahar
Atsumi, Tatsuya
Avcin, Tadej
Belmont, Michael H.
Bertolaccini, Maria Laura
Branch, D. Ware
Carvalheiras, Graziela
Casini, Alessandro
Cervera, Ricard
Cohen, Hannah
Costedoat-Chalumeau, Nathalie
Crowther, Mark
de Jesus, Guilherme
Delluc, Aurelien
Desai, Sheetal
De Sancho, Maria
Devreese, Katrien M.
Diz-Kucukkaya, Reyhan
Duarte-Garcia, Ali
Frances, Camille
Garcia, David
Gris, Jean-Christophe
Jordan, Natasha
Leaf, Rebecca K.
Kello, Nina
Knight, Jason S.
Laskin, Carl
Lee, Alfred I.
Legault, Kimberly
Levine, Steve R.
Levy, Roger A.
Limper, Maarten
Lockshin, Michael D.
Mayer-Pickel, Karoline
Musial, Jack
Meroni, Pier Luigi
Orsolini, Giovanni
Ortel, Thomas L.
Pengo, Vittorio
Petri, Michelle
Pons-Estel, Guillermo
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) : 1258 - 1270
[10] Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
Barbhaiya, Medha
Zuily, Stephane
Ahmadzadeh, Yasaman
Amigo, Mary-Carmen
Avcin, Tadej
Bertolaccini, Maria Laura
Branch, D. Ware
de Jesus, Guilherme
Devreese, Katrien M. J.
Frances, Camille
Garcia, David
Guillemin, Francis
Levine, Steven R.
Levy, Roger A.
Lockshin, Michael D.
Ortel, Thomas L.
Seshan, Surya V.
Tektonidou, Maria
Wahl, Denis
Willis, Rohan
Naden, Ray
Costenbader, Karen
Erkan, Doruk
[J]. ARTHRITIS CARE & RESEARCH, 2021, 73 (10) : 1490 - 1501

← 1 2 3 4 5 →